FDA OKs Octapharma’s IVIG to Begin Phase 3 Trial for Severe COVID-19
May 22, 2020
Officials with the FDA have approved Octapharma’s investigational new drug (IND) application for intravenous immune globulin (IVIG) (Human, Octagam 10%) therapy.
Recent Content
Drug Interaction Concerns for Potential COVID-19 Treatments
May 22, 2020
A close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.
Coronavirus News Roundup: Progress in Vaccine Development, Clarification on Pharmacist-Provided Testing
May 22, 2020
Here's a roundup of the latest coronavirus-related news.
Part 2: Pharmacist, Technician Safety and Mental Health Amid COVID-19
May 22, 2020
In part 2 of our interview, Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), discussed the results of their recent survey, which found that many pharmacists and pharmacy technicians feel unsafe from COVID-19 at their workplaces.
AstraZeneca Receives $1 Billion for Development of University of Oxford Vaccine for COVID-19
May 21, 2020
AstraZeneca has received funds exceeding $1 billion from the US Biomedical Advanced Research and Development Authority (BARDA) for the development, production, and delivery of the University of Oxford’s coronavirus disease 2019 (COVID-19) vaccine candidate.
Effect of Vitamin D Intake During Pregnancy on Offspring
May 21, 2020
Supplementation during pregnancy can have potential positive health outcomes for offspring.
HHS-Industry Partnership to Expand US Stockpile of Essential Drug Ingredients During Pandemic
May 21, 2020
The US Department of Health & Human Services partners with Phlow Corporation team to prevent drug shortages during the current pandemic and in future public health emergencies.
HHS Overrides State Barriers to Pharmacist-Provided COVID-19 Testing
May 20, 2020
A new guidance from the US Department of Health & Human Services (HHS) paves the way for pharmacists nationwide to administer coronavirus disease 2019 (COVID-19) tests.
Pharmacist, Technician Safety and Mental Health Amid COVID-19
May 20, 2020
Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), joined Drug Topics® to discuss their recent survey that pinpointed where pharmacists are feeling most unprotected during the pandemic.
FDA Approves Olaparib for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer
May 20, 2020
Approximately 20% to 30% of men with metastatic castration-resistant prostate cancer have HRR gene mutation.
